Roche's Genentech division has formed an R&D partnership with Arsenal Biosciences focusing on developing and refining the biotech's programmable T cell-based therapies platform. Genentech is providing ...
There's a new player on the antibody-drug conjugate (ADC) scene. UK-based Pheon Therapeutics has entered stage right with $68 million in funding that will be used to fund development of a pipeline of ...
Abstract: Programmable metasurface based on the design philosophy of information metasurfaces have attracted widespread attention in Internet of Things (IoT) in recent years due to their advantages of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results